Here, the authors describe the effector cell populations and immunosuppressive networks that are present in renal cell carcinoma (RCC) tumours. They also discuss the use of immune checkpoint inhibitors and novel approaches such as adoptive cell therapy in patients with RCC.
- C. Marcela Díaz-Montero
- Brian I. Rini
- James H. Finke
